Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for SINT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 61.50%
March 31, 2026 37.89%
December 31, 2025 9.66%
September 30, 2025 -31.73%
June 30, 2025 -63.58%
March 31, 2025 -18.16%
December 31, 2024 30.07%
September 30, 2024 32.17%
June 30, 2024 26.54%
March 31, 2024 6.40%
December 31, 2023 1.00%
September 30, 2023 14.45%
June 30, 2023 -0.79%
March 31, 2023 15.40%
December 31, 2022 59.35%
September 30, 2022 13.38%
June 30, 2022 -12.08%
March 31, 2022 -116.3%
December 31, 2021 -95.15%
September 30, 2021 -48.95%
June 30, 2021 -116.5%
March 31, 2021 -100.3%
December 31, 2020 -92.24%
September 30, 2020 -171.2%
June 30, 2020 20.10%
Date Value
March 31, 2020 19.81%
December 31, 2019 25.79%
September 30, 2019 12.72%
June 30, 2019 20.36%
March 31, 2019 18.56%
December 31, 2018 41.05%
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017
June 30, 2017 77.49%
March 31, 2017 74.86%
December 31, 2016 75.85%
September 30, 2016 77.35%
June 30, 2016 74.72%
March 31, 2016 78.60%
December 31, 2015 66.14%
September 30, 2015 66.08%
June 30, 2015 71.49%
March 31, 2015 67.91%
December 31, 2014 47.21%
September 30, 2014 67.67%
June 30, 2014 72.53%
March 31, 2014 71.47%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
ClearPoint Neuro, Inc. 59.79%
Abbott Laboratories 52.64%
AngioDynamics, Inc. 50.87%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%

Gross Profit Margin (Quarterly) Related Metrics